The CLN5 gene gives your cells instructions for a protein that helps clear and recycle waste, especially in the brain. When both copies are not working properly, waste can build up inside cells and lead to CLN5 disease, a rare inherited form of Batten disease. This gene plays an important role in keeping nerve cells healthy over time. Children with CLN5 disease may gradually develop vision loss, seizures, trouble with movement and balance, and loss of skills they had already learned.
What is a gene?
Genes are stretches of DNA that give your cells instructions to make molecules or regulate activities in the body. Some genes carry the directions for producing proteins, which do much of the cell’s work. Others mainly control when certain processes happen, where they happen, and how strongly they run. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
CLN5Gene function
What if the gene works
In your cells, the CLN5 gene helps lysosomes, the cell’s recycling centers, break down and clear worn out materials. This supports normal cell cleanup, especially in brain cells.
Risk
What if the gene does not work
Changes in the CLN5 gene can cause CLN5 disease, a childhood condition affecting the brain and eyes. Children often develop vision loss, seizures, and movement and learning decline, and symptoms can range from slower to faster progression depending on how much CLN5 function remains.
Treatment
What does that mean for your treatment
No CLN5-specific treatment or drug selection approach is currently established for people with a pathogenic variant in the CLN5 gene. The CLN5 gene is being studied as a target for experimental gene therapy and other early stage treatments for CLN5-related neuronal ceroid lipofuscinosis.
Conditions associated with CLN5
Gene function
What if the gene works
Inside your cells, the CLN5 gene supports the everyday cleanup system that keeps materials moving to the right place. Its protein mainly works in lysosomes, small compartments that digest and recycle worn out cell parts. Understanding CLN5 gene function helps explain how cells manage routine waste handling in a steady, organized way.
The CLN5 gene helps lysosomes process and recycle used cell material. This supports the normal breakdown of worn out proteins, fats, and other cell parts.
CLN5 supports the pathway that moves materials into lysosomes for handling. By keeping this traffic organized, your cells can sort, clear, and reuse material more smoothly.
Inside lysosomes, CLN5 works with other proteins that carry out cleanup tasks. This cooperation helps recycling steps stay coordinated during everyday cell activity.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help account for normal differences between people, such as appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect at all and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions to a greater extent and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CLN5 gene can make the CLN5 protein misfold, break down too soon, or fail to reach lysosomes, the cell's recycling compartments. Some variants leave a small amount of working protein, while more disruptive variants can lead to little or none. These effects of CLN5 gene variants on protein function can change how strongly waste builds up inside cells. In CLN5 disease, more severe loss of function often links to earlier and more pronounced symptoms.
How variants are linked to conditions
Pathogenic variants in the CLN5 gene cause CLN5 disease, a form of Batten disease also called neuronal ceroid lipofuscinosis type 5. This condition usually begins in childhood and is linked to seizures, vision loss, changes in movement, and a gradual decline in learning and daily skills. In most affected people, the diagnosis is confirmed when both copies of the CLN5 gene carry pathogenic variants.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are widely found in the general population. Most do not have a direct effect on health and simply add to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CLN5, risk is mainly set by the gene changes inherited in a family rather than by lifestyle or environmental factors. A child is affected when they inherit nonworking copies from both parents, and there is not enough evidence to say that diet, exercise, or other everyday factors change that risk.
Inheritance of CLN5 variants
CLN5 gene variants linked to CLN5 disease are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy of the CLN5 gene from each parent. When both parents carry one CLN5 variant, each pregnancy has a 25% chance of the child inheriting both variants and having the condition, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy. Boys and girls are affected equally because the CLN5 gene is on an autosome, not a sex chromosome.
What does my CLN5 result mean for my family?
For CLN5, the main family concern is usually that close relatives may also carry the same gene change, even if they are healthy. This condition is typically passed down in a recessive pattern, so brothers and sisters may be affected or may be carriers, and relatives planning children may also want to know their carrier status. The meaning for family members depends on the exact CLN5 result in the family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CLN5 variants, often called CLN5 genetic testing, uses a blood or saliva sample to read the CLN5 gene and look for changes in its DNA code. Results can show whether a disease-causing variant is present and, in the right clinical setting, can help confirm a genetic diagnosis.
When should I consider getting a genetic test?
Consider CLN5 genetic testing if a child has signs of Batten disease, such as seizures, vision loss, trouble walking, or losing skills they had already learned. Testing can also help if Batten disease runs in the family or if a relative is known to carry a CLN5 change.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal depends on the condition and the kind of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood along with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, how strongly the drug acts, or how sensitive someone is to side effects. This helps explain why the same treatment works well for one person, works less well for another, or causes more unwanted effects in some people.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect the way people respond to medications. It looks at connections between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed, personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the CLN5 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so any concerns about symptoms, treatments, or side effects are best discussed with your doctor.
History
CLN5 entered medical genetics through studies of children with a form of neuronal ceroid lipofuscinosis first recognized in Finland and often called the Finnish variant of late infantile disease. Initially understood only through visible traits, later recognized as tied to a specific gene, this condition helped researchers separate one NCL type from others that looked similar in early childhood. In the 1990s, linkage studies mapped the cause to chromosome 13, and the CLN5 gene was identified soon after. From these first observations, research expanded steadily, allowing families in affected communities to receive clearer genetic answers. That work also helped refine how doctors classify NCL conditions across different populations.